Review of Cutaneous Graft-vs-Host Disease

被引:11
|
作者
Ballester-Sanchez, R. [1 ]
Navarro-Mira, M. [1 ]
Sanz-Caballer, J. [2 ]
Botella-Estrada, R. [1 ]
机构
[1] Hosp Univ & Politecn La Fe Valencia, Serv Dermatol, Valencia, Spain
[2] Hosp Univ & Politecn La Fe Valencia, Serv Hematol & Hemoterapia, Valencia, Spain
来源
ACTAS DERMO-SIFILIOGRAFICAS | 2016年 / 107卷 / 03期
关键词
Cutaneous graft-versus-host disease; Hematopoietic stem cell transplant; Dermopathology;
D O I
10.1016/j.ad.2015.10.003
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Graft-vs-host disease (GVHD) is a multisystem disease that arises as a complication of allogeneic hematopoietic stem cell transplant. It is due to recognition of the recipient's tissues by immune cells from the donor. The skin and mucous membranes are the organs most commonly affected. GVHD is classified as acute or chronic depending on the pathophysiology and clinical presentation. Acute GVHD typically presents with the triad of rash, diarrhea, and hyperbilirubinemia, and treatment is based on systemic corticosteroid and immunosuppressant therapy. The cutaneous manifestations of chronic GVHD are divided into sclerodermiform and nonsclerodermiform, and the mucous membranes and skin appendages may also be affected.The diagnosis is mainly clinical, but skin biopsy can help in doubtful cases. Treatment can be topical, systemic, or physical, depending on the size, site, and depth of the lesions and the involvement of other organs. (C) 2015 Elsevier Espana, S.L.U. and AEDV. All rights reserved.
引用
收藏
页码:183 / 193
页数:11
相关论文
共 50 条
  • [41] Acute graft-vs-host disease: Pathobiology and management
    Goker, H
    Haznedaroglu, IC
    Chao, NJ
    EXPERIMENTAL HEMATOLOGY, 2001, 29 (03) : 259 - 277
  • [42] GRAFT-VS-HOST REACTION
    SCHERZER, JM
    ARCHIVES OF DERMATOLOGY, 1978, 114 (02) : 289 - 289
  • [43] GRAFT-VS-HOST REACTION
    SAURAT, JH
    GLUCKMAN, E
    ARCHIVES OF DERMATOLOGY, 1978, 114 (05) : 801 - 802
  • [44] A short view of chronic graft-vs-host disease
    Bali, Cagla
    Ozmete, Ozlem
    Ozyilkan, Nesrin Bozdogan
    Akin, Sule
    Aribogan, Anis
    JOURNAL OF CLINICAL ANESTHESIA, 2016, 30 : 4 - 5
  • [45] Histopathologic and immunophenotypic features of cutaneous solid organ transplant-associated graft-vs-host disease: Comparison with acute hematopoietic cell transplant-associated graft-vs-host disease and cutaneous drug eruption
    Russell, Aaron J.
    Musiek, Amy C.
    Staser, Karl W.
    Rosman, Ilana S.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2021, 48 (12) : 1480 - 1488
  • [46] Graft-vs-host disease as a complication of lung transplantation
    Smith, Douglas M.
    Agura, Edward D.
    Ausloos, Ken
    Ring, W. Steves
    Dorniati-Saad, Rana
    Klintmalm, Goran B.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (09): : 1175 - 1177
  • [47] MECHANISM FOR SUPPRESSION OF GRAFT-VS-HOST DISEASE WITH ENDOTOXIN
    THOMSON, PD
    RAMPY, PA
    JUTILA, JW
    JOURNAL OF IMMUNOLOGY, 1978, 120 (04): : 1340 - 1344
  • [48] BLOOD-TRANSFUSIONS AND GRAFT-VS-HOST DISEASE
    RAY, TL
    ARCHIVES OF DERMATOLOGY, 1990, 126 (10) : 1347 - 1350
  • [49] Life-threatening graft-vs-host disease
    Vargas-Díez, E
    García-Díez, A
    Marín, A
    Fernández-Herrara, J
    CLINICS IN DERMATOLOGY, 2005, 23 (03) : 285 - 300
  • [50] Drug Approved to Prevent Graft-vs-Host Disease
    Voelker, Rebecca
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (05): : 417 - 417